We previously reported on the partial prevention of experimental shunt-induced pulmonary arterial hypertension (PAH) by the nonselective endothelin (ET) ET-A/ET-B receptor antagonist bosentan. As the ...

A patient with pulmonary arterial hypertension (PAH) who received a modified Potts shunt exhibited improved quality of life and exercise capacity after 1 year. A case report published in ERJ Open ...

Among patients with advanced chronic obstructive pulmonary disease (COPD), an arteriovenous (AV) shunt improves physiological parameters such as cardiac output and oxygen delivery but does not have a ...

Researchers suggest "total artificial lung" approach might make double-lung transplant saf ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

V-Wave has raised $98 million to complete the clinical testing of its implant for severe heart failure and pulmonary arterial hypertension, as well as set up the device for FDA review. The company’s ...

VENOUS anastomoses connecting the portal and pulmonary veins have been shown in cirrhotic patients by post-mortem injection, 1 and there has been considerable speculation concerning their possible ...

The classical histological findings of CDH show pulmonary vascular remodeling superimposed on hypoplasia or pruning of the pulmonary vascular bed. 1 These changes in the pulmonary vasculature are ...

Please provide your email address to receive an email when new articles are posted on . “Dyspnea due to left atrial pressure overload during exercise is a hallmark of heart failure with preserved or ...